ScanVec announces third quarter 1996 results.TEL AVIV Tel Aviv (tĕl əvēv`), city (1994 pop. 355,200), W central Israel, on the Mediterranean Sea. Oficially named Tel Aviv–Jaffa, it is Israel's commercial, financial, communications, and cultural center and the core of its largest , Israel--(BUSINESS WIRE)--Nov. 6, 1996--ScanVec Co. (1990) Ltd. (NASDAQ/NMS: SVECF) announced today its revenue and operating results for the third quarter of 1996. Revenues for the third quarter were approximately ap·prox·i·mate adj. 1. Almost exact or correct: the approximate time of the accident. 2. US$2.9 million, about the same level of revenues for the corresponding period during 1995. For the nine months ended Sept. 30, 1996, ScanVec's revenues increased 11 percent to US$8.5 million from US$7.6 million for the nine months ended Sept. 30, 1995. This increase was primarily due to an increase of about 37 percent in sales to the Asian market and an approximately 10 percent increase in sales to the European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. market, which was partially offset by a six percent decrease in sales to the American American, river, 30 mi (48 km) long, rising in N central Calif. in the Sierra Nevada and flowing SW into the Sacramento River at Sacramento. The discovery of gold at Sutter's Mill (see Sutter, John Augustus) along the river in 1848 led to the California gold rush of market. The net loss for the third quarter of 1996 was US$35,631 or US$0.01 per share, compared with net income of US$501,336, or US$0.17 per share for the same period in 1995. The adverse variance The discrepancy between what a party to a lawsuit alleges will be proved in pleadings and what the party actually proves at trial. In Zoning law, an official permit to use property in a manner that departs from the way in which other property in the same locality in operating performance reflected increased selling, marketing and general administrative expenses. In the third quarter of 1996, expenses increased 31 percent to US$2.9 million, compared to US$2.3 million in the same period in 1995. Expenses have remained essentially stable for each of the three quarters of 1996. At the end of September September: see month. 1996 the company released its AccuPrint software for the graphic arts graphic arts: see aquatint; drawing; drypoint; engraving; etching; illustration; linoleum block printing; lithography; mezzotint; niello; pastel; poster; silk-screen printing; silhouette; silverpoint; sketch; stencil; woodcut and wood engraving. market, at the Seybold show in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden . Third quarter results include revenues of approximately US$100,000 from sales of AccuPrint. In addition, during October October: see month. , ScanVec released Optitex 6.0 software for the textile textile Any filament, fibre, or yarn that can be made into fabric or cloth, and the resulting material itself. The word originally referred only to woven fabrics but now includes knitted, bonded, felted, and tufted fabrics as well. market and in November November: see month. the company expects to release EnRoute 2.0 for the machinery market. Initial responses to these product releases has been encouraging and the performance of these new products is expected to contribute to growth of sales in 1997. -0- For further information, contact ScanVec President Dr. Ramon Ra·mon , Gaston Léon 1886-1963. French bacteriologist who in 1936 discovered a method of producing toxoids, leading to the development of vaccinations against diphtheria and tetanus. Harel on Nov. 7, 1996, between 8:00 a.m. - 10:00 a.m. (US time) at 508-694-9488. To the extent that this press release discusses expectations about market conditions or about market acceptance and future sales of the company's products, or otherwise makes statements about the future, such statements are forward looking and are subject to a number of risks and uncertainties that could cause results to differ materially from the statements made. These factors include the rapidly changing technology and evolving standards in the industries in which the company operates, risks associated with the acceptance of new products by individual customers and by the marketplace and other factors discussed in the business description and management's discussion and analysis Management's discussion and analysis (MD&A) A report from management to shareholders that accompanies the firm's financial statements in the annual report. It explains the period's financial results and enables management to discuss topics that may not be apparent in the financial sections of the company's Annual Report on Form 20-F and Registration Statement on Form F-1. ScanVec designs, manufactures, markets and supports a family of high-performance Adj. 1. high-performance - modified to give superior performance; "a high-performance car" superior - of high or superior quality or performance; "superior wisdom derived from experience"; "superior math students" software products for the sign making & graphic arts industries, for the textile industry and for machining applications in wood and metal carving carving, n the shaping and forming with instruments. . ScanVec's products are PC-based open-architecture solutions. Their relatively low price points and unique performance make ScanVec's products very attractive for millions of small and large manufacturers and professionals all over the world. ScanVec products are sold in 50 countries and in 21 languages, by more than 140 distributors, dealers and OEMs all over the world. -0-
ScanVec Co. (1990) Ltd.
Consolidated Statements of Income
(in U.S. dollars)
Nine Months period ended Three Months period ended
Sept. 30, Sept. 30,
1996 1995 1996 1995
Sales $8,464,969 $7,629,950 $2,869,487 $2,860,551
Cost of Sales $2,087,054 $1,338,181 $ 599,309 $ 472,854
Gross profit $6,377,915 $6,291,769 $2,270,178 $2,387,697
Research and
Development,
Gross $2,528,878 $1,837,803 $ 935,413 $ 713,311
Less royalty-
bearing grants $ 937,833 $ 539,526 $ 368,833 $ 179,526
Less capitalization
of computer software
costs $ 570,000 $ 247,991 $ 190,000 $ 67,334
R&D, Net $1,021,046 $1,050,286 $ 376,581 $ 466,451
Selling expenses,
net $4,030,442 $2,602,632 $1,321,838 $ 922,488
General &
administrative
expenses $1,797,407 $1,063,582 $ 650,734 $ 391,367
Operating income $ (470,979) $1,575,269 $ (78,975) $ 607,391
Financial Income,
net $ 206,033 $ 61,501 $ 58,164 $ 21,496
Income before taxes
on income $ (264,946) $1,636,770 $ (20,811) $ 628,887
Taxes on income $ (40,180) $ 335,662 $ 14,820 $ 127,551
Net income $ (224,766) $1,301,108 $ (35,631) $ 501,336
Minority share in
earnings of a
consolidated
subsidiary
Net income $ (224,766) $1,301,108 $ (35,631) $ 501,336
Earnings per share $ (0.05) $ 0.43 $ (0.01) $ 0.17
Average number of
shares 4,428,000 3,000,000 4,428,000 3,000,000
-0-
ScanVec Co. (1990) Ltd.
Consolidated Balance Sheet
(in U.S. dollars)
Period Ended Year Ended
Sept. 30, Dec. 31,
1996 1995
(audited)
Assets
Current Assets
Cash and cash equivalents $7,989,772 $9,458,913
Accounts receivables $2,472,687 $2,412,377
Other receivables $2,542,061 $2,323,528
$13,004,520 $14,194,818
Fixed Assets $1,724,149 $1,306,216
Other Assets $ 975,891 $ 771,180
Deferred Income Taxes --- $ 6,227
Total Assets $15,704,560 $16,278,441
Liabilities and Shareholders' Equity
Current Liabilities
Accounts Payables $ 231,987 $ 735,027
Other Current Liabilities $1,067,903 $1,104,274
$1,299,890 $1,839,301
Long Term Liabilities, net $ 256,727 $ 225,018
Deferred income taxes $ 132,711 ---
Shareholders' Equity
Share capital $9,804,217 $9,778,341
Retained Earnings $4,211,015 $4,435,781
Total Shareholders' Equity $14,015,232 $14,214,122
Total Liabilities and
Shareholders' Equity $15,704,560 $16,278,441
CONTACT: ScanVec Co. Ltd., Tel Aviv Ramon Harel, +972-3-647-4477 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion